fremanezumab (Ajovy) Report issue

Biologics mAb Approved FDA
AACT Drugs@FDA
Back

Drug Pricing Summary

VA Big4

$318.0675 - $336.0450

VA FSS

$430.5675 - $445.5825

NADAC

$612.3550 - $612.6803

Drug Product Pricing

Product $/unit Ctry. List Type
Product (units) Manufacturer
fremanezumab 225 mg / 1.5 mL (1.5 mL INJECTION) $318.0675 VA Big4
  • AJOVY (1.3)
    		•  Teva Pharmaceuticals USA, Inc.
    fremanezumab 225 mg / 1.5 mL (1.5 mL INJECTION) $336.0450 VA Big4
  • AJOVY (1.3)
    		•  Teva Pharmaceuticals USA, Inc.
    fremanezumab 225 mg / 1.5 mL (1.5 mL INJECTION) $430.5675 VA FSS
  • AJOVY (1.3)
    		•  Teva Pharmaceuticals USA, Inc.
    fremanezumab 225 mg / 1.5 mL (1.5 mL INJECTION) $445.5825 VA FSS
  • AJOVY (1.3)
    		•  Teva Pharmaceuticals USA, Inc.
    fremanezumab 225 mg / 1.5 mL (1.5 mL INJECTION) $612.3550 NADAC brand
  • AJOVY (0.7)
    		•  Teva Pharmaceuticals USA, Inc.
    fremanezumab 225 mg / 1.5 mL (1.5 mL INJECTION) $612.6803 NADAC brand
  • AJOVY (0.7)
    		•  Teva Pharmaceuticals USA, Inc.

    Note: This drug pricing data is preliminary, incomplete, and may contain errors.

    Feedback

    Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

    Report issue